Crystal Lee Carmicheal, PA-C

Crystal Carmicheal practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Crystal Carmicheal's NPI, 1629403423, was assigned on September 11, 2013. Crystal Carmicheal holds Texas license PA15093.

Crystal Carmicheal's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Crystal Carmicheal's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Crystal Carmicheal to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Crystal Carmicheal practices. Vendor and product names are available with a free account.

Physician assistant is Crystal Carmicheal's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Crystal Carmicheal is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Crystal Carmicheal is licensed in Texas.

Dmand AI lists acute skin infection among the conditions Crystal Carmicheal treats.

CMS data shows 118 Medicare services from Crystal Carmicheal across 3 procedure codes in 2024, for 103 Medicare patients. Medicare paid $5,956 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 103 Medicare patients who saw Crystal Carmicheal in 2024. The largest group is 65 to 74, with 56 patients. 75% of them have high blood pressure, and 66% have high cholesterol. Their average risk score is 3.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Crystal Carmicheal's median patient age at 69, with 41% women.

In 2024, Crystal Carmicheal wrote 861 Medicare Part D claims for 84 patients. 89% of them were for generic drugs. CMS names the drug for 618 of them, across 20 drugs with 11 or more claims each, at $559,087 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Crystal Carmicheal for performance year 2024, reported as part of a group. Crystal Carmicheal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Crystal Carmicheal as offering telehealth.

CMS Open Payments shows 23 general payments to Crystal Carmicheal from 9 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 59% of the total. Astellas Pharma US Inc paid the most, $444.

Crystal Carmicheal is a member of AAPA.